InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Browse the full record of transactions filed by Katabi Maha, Director. Director active across 2 companies, notably Vera Therapeutics, Inc.. Cumulatively, 4 filings have been logged. Regulator: SEC (Form 4). All data is openly available.
Declarations4 total
3,401,544 shares
Common Stock
SEC:0001104659-21-089437·
3,401,544 shares
Common Stock
SEC:0001104659-21-089437:0·
2,187,504 shares
Class A Common Stock
SEC:0001209191-21-033812·
2,187,504 shares
Class A Common Stock
SEC:0001209191-21-033812:0·
4 of 4 declarations
About Katabi Maha
Maha Katabi is a Director at Vera Therapeutics, Inc. and Aerovate Therapeutics, Inc. In this role, she contributes to the strategy and governance of the companies. Vera Therapeutics, Inc. is a biopharmaceutical company focused on developing treatments for autoimmune diseases, while Aerovate Therapeutics, Inc. focuses on respiratory therapies. Maha Katabi brings valuable expertise in biotechnology and healthcare.
